MCLEAN, Va. / Jul 16, 2025 / Business Wire / Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the publication of its 2024 Corporate Responsibility Report.
The 2024 report showcases the Company’s strategic momentum in advancing its sustainability priorities during a pivotal year of transformation. The report emphasizes Claritev’s continued focus on managing, tracking and disclosing its social and environmental performance, reinforcing its commitment to accountability and responsible growth.
“I’ve never been more excited about the opportunity ahead—to reshape healthcare through technology, data and insights that drive affordability, transparency and quality across the healthcare ecosystem,” said Travis Dalton, Chairman, and CEO of Claritev.
Dalton continued, “I’m especially proud of our efforts to drive greater access and equity in healthcare. Our partnership with the National Rural Health Association helps extend the reach of our technology and data science capabilities to underserved communities.”
The report outlines Claritev’s progress across key corporate responsibility priorities, including access to healthcare, data privacy and security, people strategy, ethics and transparency, and sustainable operations. Notable 2024 highlights include:
The full report is available on Claritev’s website at the following link: https://www.claritev.com/corporate-responsibility/
About Claritev
Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality. Led by a team of deeply experienced associates, data scientists and innovators, Claritev provides cutting-edge solutions and services fueled by multiple data sources and over 40 years of claims repricing experience. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design. By focusing on purpose-built solutions that support all key players – including payors, employers, patients, providers and third parties – Claritev aims to make healthcare more accessible and affordable for all. For more information, visit claritev.com.
Last Trade: | US$29.20 |
Daily Volume: | 0 |
Market Cap: | US$472.160M |
August 06, 2025 July 08, 2025 May 22, 2025 May 08, 2025 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load